OP 04
Analysis of demographic and clinical characteristics of primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis patients
P. Akyol, A. Yıldız, M. Albayrak, H. Afacan Öztürk, S. Maral, M. Reis Aras*, F. YıLmaz, B. Saglam, M. Tıglıoglu, U. Malkan
Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey
Lido
2477
Vezesque se leu este artigo
1152
Total PDF
1325
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 25 | 7 | 32 |
| 2025 5 | 64 | 18 | 82 |
| 2025 4 | 59 | 13 | 72 |
| 2025 3 | 88 | 12 | 100 |
| 2025 2 | 62 | 15 | 77 |
| 2025 1 | 43 | 22 | 65 |
| 2024 12 | 33 | 18 | 51 |
| 2024 11 | 43 | 15 | 58 |
| 2024 10 | 26 | 16 | 42 |
| 2024 9 | 33 | 20 | 53 |
| 2024 8 | 32 | 22 | 54 |
| 2024 7 | 31 | 19 | 50 |
| 2024 6 | 39 | 26 | 65 |
| 2024 5 | 31 | 26 | 57 |
| 2024 4 | 17 | 18 | 35 |
| 2024 3 | 22 | 19 | 41 |
| 2024 2 | 26 | 23 | 49 |
| 2024 1 | 22 | 27 | 49 |
| 2023 12 | 16 | 26 | 42 |
| 2023 11 | 43 | 42 | 85 |
| 2023 10 | 19 | 24 | 43 |
| 2023 9 | 28 | 34 | 62 |
| 2023 8 | 19 | 15 | 34 |
| 2023 7 | 26 | 14 | 40 |
| 2023 6 | 22 | 24 | 46 |
| 2023 5 | 18 | 13 | 31 |
| 2023 4 | 19 | 1 | 20 |
| 2023 3 | 16 | 16 | 32 |
| 2023 2 | 14 | 18 | 32 |
| 2023 1 | 15 | 13 | 28 |
| 2022 12 | 14 | 23 | 37 |
| 2022 11 | 10 | 30 | 40 |
| 2022 10 | 18 | 31 | 49 |
| 2022 9 | 13 | 28 | 41 |
| 2022 8 | 12 | 17 | 29 |
| 2022 7 | 9 | 24 | 33 |
| 2022 6 | 12 | 11 | 23 |
| 2022 5 | 13 | 18 | 31 |
| 2022 4 | 12 | 26 | 38 |
| 2022 3 | 14 | 16 | 30 |
| 2022 2 | 13 | 23 | 36 |
| 2021 1 | 12 | 18 | 30 |
| 2021 12 | 7 | 26 | 33 |
| 2021 11 | 20 | 19 | 39 |
| 2021 10 | 18 | 24 | 42 |
| 2021 9 | 15 | 21 | 36 |
| 2021 8 | 24 | 33 | 57 |
| 2021 7 | 22 | 29 | 51 |
| 2021 6 | 16 | 22 | 38 |
| 2021 5 | 22 | 25 | 47 |
| 2021 4 | 24 | 37 | 61 |
| 2021 3 | 18 | 27 | 45 |
| 2021 2 | 12 | 10 | 22 |
| 2020 1 | 11 | 14 | 25 |
| 2020 12 | 6 | 10 | 16 |
| 2020 11 | 7 | 14 | 21 |
Mostrar tudo
